Developing a faster and cheaper method for retinal imaging using advanced technology
Official title: High-Speed, Low-Cost, Image Remapping Spectral Domain Full-Field Optical Coherence Tomography for Retinal Imaging
Funded at University of Southern California · NIH-10851922 · Data updated 2026-11-12
This study is working on a new way to take pictures of the retina that is faster and cheaper, so more people, especially in rural areas, can get the eye care they need to catch problems early.
Quick facts
| Grant type | R21 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Southern California NIH-funded |
| Lab location | 1 site (Los Angeles, UNITED STATES) |
| Project start | July 1, 2023 |
| Project end | June 30, 2025 |
| Funding year | 2024 |
| Award (this year) | $195,309 |
| NIH project number | 5R21EY035108-02 |
| Project ID | NIH-10851922 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are individuals at risk for retinal diseases, particularly those in underserved or rural areas where access to current imaging technology is limited.
✕Less likely to help
Patients who do not have retinal diseases or those who already have access to advanced imaging technologies may not benefit from this research.
What this research studies
This research focuses on improving Optical Coherence Tomography (OCT), a technique used for imaging the retina, by creating a new system that captures images more quickly and at a lower cost. The approach involves using advanced manufacturing techniques and high-resolution cameras to enhance image quality and stability, making it suitable for use in various healthcare settings, including rural and underserved areas. By addressing the limitations of current OCT systems, this research aims to make retinal imaging more accessible and effective for early diagnosis of retinal diseases.
Why it matters
Potential benefit: If successful, this research could lead to more accessible and affordable retinal imaging, improving early diagnosis and treatment of retinal diseases for many patients.
How similar studies have gone: Previous research has shown promise in improving imaging techniques for retinal diagnostics, suggesting that this approach could also yield significant advancements.
Where this research is happening
-
University of Southern California
Los Angeles, United States Active
Researchers
- Principal investigator: Applegate, Brian E. — University of Southern California
- Study coordinator: Applegate, Brian E.
Related research
Other NIH-funded projects on the same topics.
-
RNA dysregulation in a rare childhood brain disorder (PCH1b)
Researchers are studying a rare genetic brain disease in young children to understand how RNA processing goes wrong and leads to damage in the cerebellum and brainstem.
-
Studying how diverse signals come from similar molecules at glutamatergic synapses
A project at a university explores how synapses in the brain create different signals from a shared set of molecules, using a fruit-fly model to understand how this could relate to neurodevelopmental and neurodegenerative diseases.
-
How brain chemicals may influence tau clumps in Alzheimer’s disease
A study from USC explores how certain brain chemicals might influence the clumping of tau protein related to Alzheimer’s disease, aiming to identify factors that could affect disease progression.
-
GLP-1 medicines and brain health: real-world clues about dementia risk
A nationwide study will follow adults 21 and older using GLP-1 medicines to see how these drugs relate to memory, thinking, and dementia risk in real life.
-
Male pesticide exposure and reproductive health through epigenetics
This project looks at how a man’s exposure to pesticides might affect his fertility and the health of his future children through changes in DNA.
-
Global effort to harmonize fMRI findings in psychiatry
A large, international effort will standardize how brain MRI data are collected and analyzed in people with various mental health conditions to improve consistency and discovery.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.